Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
Article
[키워드] adenovirus-based
antibody
Antibody avidity
avidity
bind
binding
binding antibody
cellular receptor
collected
cross-protection
domain
dose
elicited
epitope
exhibit
Heterologous
high affinity
Immunity
increase
mRNA vaccine
Mutation
natural infection
Neutralizing
Neutralizing activity
Neutralizing antibodies
neutralizing antibody
Neutralizing titer
omicron
pandemic
patients
Protective antibody
RBD
RBD-binding IgG
remained
response
Sample
SARS-CoV-2
SARS-CoV-2 infected patient
SARS-CoV-2 spike protein
subject
tested
the RBD
the spike protein
vaccination
Vaccine
vaccine dose
vaccinees
Vaccines
variant
virus
wild-type
wild-type SARS-CoV-2
wild-type virus
[DOI] 10.1155/2022/4813199 PMC 바로가기
[DOI] 10.1155/2022/4813199 PMC 바로가기